The FDA approved Eli Lilly's once-weekly insulin Onswik for type 2 diabetes, potentially cutting injections by more than 300 per year.
FDA Clears Weekly Insulin Shot That Could Cut Injections by 300 a Year
The FDA approved Eli Lilly's once-weekly insulin Onswik for type 2 diabetes, potentially cutting injections by more than 300 per year.